Published in BMC Pediatr on February 15, 2010
European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab (2014) 1.26
Detection and treatment of congenital hypothyroidism. Nat Rev Endocrinol (2011) 0.95
Transient hypothyroidism at 3-year follow-up among cases of congenital hypothyroidism detected by newborn screening. J Pediatr (2012) 0.87
Permanent and transient congenital hypothyroidism in Fayoum, Egypt: a descriptive retrospective study. PLoS One (2013) 0.85
Screening for congenital hypothyroidism: comparison of borderline screening cut-off points and the effect on the number of children treated with levothyroxine. Eur Thyroid J (2013) 0.84
Prediction of congenital hypothyroidism based on initial screening thyroid-stimulating-hormone. BMC Pediatr (2016) 0.83
Permanent and Transient Congenital Hypothyroidism in Hamadan West Province of Iran. Int J Endocrinol Metab (2016) 0.78
Congenital Hypothyroidism Long-Term Follow-up Project: Navigating the Rough Waters of a Multi-Center, Multi-State Public Health Project. J Genet Couns (2014) 0.75
Effect of prolonged discontinuation of L-thyroxine replacement in a child with congenital hypothyroidism. Case Rep Endocrinol (2012) 0.75
Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics (2006) 2.92
Increased incidence of congenital malformations in children with transient thyroid-stimulating hormone elevation on neonatal screening. J Pediatr (1998) 2.80
Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab (2007) 2.62
Impact of specific medical interventions on reducing the prevalence of mental retardation. Arch Pediatr Adolesc Med (2006) 2.03
Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr (2008) 1.73
Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer (2009) 1.54
Outcome for congenital hypothyroidism. Arch Dis Child (1984) 1.51
Children with congenital hypothyroidism and their siblings: do they really differ? Pediatrics (2005) 1.34
Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998. Teratology (2000) 1.23
Risk factors for congenital hypothyroidism: results of a population case-control study (1997-2003). Eur J Endocrinol (2005) 1.22
Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr (2005) 1.18
The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics (2010) 1.14
Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. JAMA (2003) 1.07
Random variability in congenital hypothyroidism from thyroid dysgenesis over 16 years in Québec. J Clin Endocrinol Metab (2007) 1.07
Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism. J Pediatr (2005) 1.03
Prevalence of congenital hypothyroidism--current trends and future directions: workshop summary. Pediatrics (2010) 0.98
A comparison between the neurological and intellectual abnormalities in children and adults with congenital hypothyroidism. Eur J Pediatr (1986) 0.97
Improvement in screening performance and diagnosis of congenital hypothyroidism in Scotland 1979-2003. Arch Dis Child (2006) 0.95
Update: newborn screening for sickle cell disease--California, Illinois, and New York, 1998. MMWR Morb Mortal Wkly Rep (2000) 0.94
Congenital hypothyroidism in Western Australia 1981-1998. J Paediatr Child Health (2002) 0.92
Congenital hypothyroidism in Sweden. Psychomotor development in patients detected by clinical signs and symptoms. Acta Paediatr Scand (1981) 0.88
Transient primary hypothyroidism in the newborn: experience of the Victorian Neonatal Thyroid Screening Programme. Aust Paediatr J (1989) 0.81
Athyreosis, dysgenesis, and dyshormonogenesis in congenital hypothyroidism. Pediatr Endocrinol Rev (2006) 0.80
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol (2007) 4.01
The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med (2010) 2.81
Strategies for implementing screening for critical congenital heart disease. Pediatrics (2011) 2.72
Quantifying the health benefits of genetic tests: the importance of a population perspective. Genet Med (2006) 2.11
Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics (2009) 1.77
Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr (2008) 1.73
Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation (2009) 1.72
Health care expenditures for infants and young children with Down syndrome in a privately insured population. J Pediatr (2008) 1.70
Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007. Am J Prev Med (2010) 1.62
Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet (2009) 1.62
Impact of business cycles on US suicide rates, 1928-2007. Am J Public Health (2011) 1.58
Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer (2009) 1.54
Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch Intern Med (2012) 1.53
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. Med Decis Making (2010) 1.45
Professional Fee Ratios for US Hospital Discharge Data. Med Care (2015) 1.42
Economic evaluation of a neural tube defect recurrence-prevention program. Am J Prev Med (2008) 1.42
Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol (2007) 1.32
Cost-effectiveness of routine screening for critical congenital heart disease in US newborns. Pediatrics (2013) 1.28
Issues related to the diagnosis and treatment of autism spectrum disorders. Ment Retard Dev Disabil Res Rev (2007) 1.26
Measures of follow-up in early hearing detection and intervention programs: a need for standardization. Am J Audiol (2008) 1.20
Children with orofacial clefts: health-care use and costs among a privately insured population. Public Health Rep (2009) 1.16
Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med (2010) 1.16
Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection? Birth Defects Res A Clin Mol Teratol (2013) 1.15
Attention-deficit/hyperactivity disorder symptoms and child maltreatment: a population-based study. J Pediatr (2008) 1.14
Autism spectrum disorders and health care expenditures: the effects of co-occurring conditions. J Dev Behav Pediatr (2012) 1.14
The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics (2010) 1.14
Medical expenditures for children with an autism spectrum disorder in a privately insured population. J Autism Dev Disord (2007) 1.10
Health state preference scores of children with spina bifida and their caregivers. Qual Life Res (2005) 1.08
Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population. J Child Neurol (2008) 1.04
Hospital use and associated costs of children aged zero-to-two years with craniofacial malformations in Massachusetts. Birth Defects Res A Clin Mol Teratol (2009) 1.04
Healthcare expenditures for privately insured people with cystic fibrosis. Pediatr Pulmonol (2009) 1.01
Factors associated with late detection of critical congenital heart disease in newborns. Pediatrics (2013) 1.01
Attention-deficit/hyperactivity disorder, conduct disorder, and young adult intimate partner violence. Arch Gen Psychiatry (2010) 1.01
Cost savings from universal newborn hearing screening. Pediatrics (2006) 0.99
Prevalence of congenital hypothyroidism--current trends and future directions: workshop summary. Pediatrics (2010) 0.98
Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States. Fertil Steril (2011) 0.98
Determining the effect of newborn hearing screening legislation: an analysis of state hearing screening rates. Public Health Rep (2007) 0.97
Health care expenditures associated with venous thromboembolism among children. Thromb Res (2011) 0.96
The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality. Am J Prev Med (2012) 0.95
The economic impact of an urban asthma management program. Am J Manag Care (2009) 0.95
Cost-effectiveness of a folic acid fortification program in Chile. Health Policy (2007) 0.95
Health state preference scores for children with permanent childhood hearing loss: a comparative analysis of the QWB and HUI3. Qual Life Res (2008) 0.93
Sexual orientation and suicide ideation, plans, attempts, and medically serious attempts: evidence from local Youth Risk Behavior Surveys, 2001-2009. Am J Public Health (2013) 0.93
Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis. Med Decis Making (2008) 0.91
Points to consider in assessing and appraising predictive genetic tests. J Community Genet (2010) 0.91
Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia. Pediatrics (2013) 0.90
A national profile of health care and family impacts of children with muscular dystrophy and special health care needs in the United States. J Child Neurol (2011) 0.89
Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy. Genet Med (2011) 0.89
Health utility elicitation: is there still a role for direct methods? Pharmacoeconomics (2012) 0.89
Trends in venous thromboembolism-related hospitalizations, 1994-2009. Pediatrics (2012) 0.87
Revival of the intrauterine device: increased insertions among US women with employer-sponsored insurance, 2002-2008. Contraception (2011) 0.87
Disability among individuals with sickle cell disease: literature review from a public health perspective. Am J Prev Med (2011) 0.87
Hospitalization for urinary tract infections and the quality of preventive health care received by people with spina bifida. Disabil Health J (2009) 0.86
The role of health technology assessment in coverage decisions on newborn screening. Int J Technol Assess Health Care (2011) 0.85
Medical expenditures of children in the United States with fetal alcohol syndrome. Neurotoxicol Teratol (2010) 0.85
Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening. Pediatr Pulmonol (2010) 0.84
Health care expenditures among children with and those without spina bifida enrolled in Medicaid in North Carolina. Birth Defects Res A Clin Mol Teratol (2011) 0.84
Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity. Genet Med (2012) 0.84
Developing public health surveillance for deep vein thrombosis and pulmonary embolism. Am J Prev Med (2011) 0.84
Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening. Ethn Health (2011) 0.84
Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children. Res Dev Disabil (2012) 0.84
Measuring health and well-being effects in family caregivers of children with craniofacial malformations. Qual Life Res (2011) 0.83
Decision analysis, economic evaluation, and newborn screening: challenges and opportunities. Genet Med (2012) 0.82
Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality. Trop Med Int Health (2014) 0.81
Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016. Emerg Infect Dis (2017) 0.81
CDC Grand Rounds: preventing hospital-associated venous thromboembolism. MMWR Morb Mortal Wkly Rep (2014) 0.81
Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014. MMWR Morb Mortal Wkly Rep (2016) 0.80
Factors associated with high hospital resource use in a population-based study of children with orofacial clefts. Birth Defects Res A Clin Mol Teratol (2015) 0.79
Prevalence of venous thromboembolism among privately insured US adults. Arch Intern Med (2010) 0.79
Prevention of orofacial clefts caused by smoking: implications of the Surgeon General's report. Birth Defects Res A Clin Mol Teratol (2014) 0.79
Hospitalizations and associated costs in a population-based study of children with Down syndrome born in Florida. Birth Defects Res A Clin Mol Teratol (2014) 0.78
Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data. BMC Infect Dis (2012) 0.78
Racial/ethnic differences in hospital use and cost among a statewide population of children with Down syndrome. Res Dev Disabil (2013) 0.78
Outpatient medical conditions among children and adults with spina bifida in the United States: Frequency and expenditures. J Pediatr Rehabil Med (2010) 0.78
Correlates of in-hospital deaths among hospitalizations with pulmonary embolism: findings from the 2001-2008 National Hospital Discharge Survey. PLoS One (2012) 0.78
U.S. trends in computed tomography use and diagnoses in emergency department visits by patients with symptoms suggestive of pulmonary embolism, 2001-2009. Acad Emerg Med (2013) 0.78
Inpatient Hospitalization Costs Associated with Birth Defects Among Persons of All Ages - United States, 2013. MMWR Morb Mortal Wkly Rep (2017) 0.78
The continuing health burden of congenital hypothyroidism in the era of neonatal screening. J Clin Endocrinol Metab (2011) 0.77
Disparities in health care utilization by race among teenagers and young adults with muscular dystrophy. Med Care (2014) 0.77
Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus. J Inherit Metab Dis (2010) 0.77
What is the value for money of prenatal carrier screening for spinal muscular atrophy? Too soon to say. Am J Obstet Gynecol (2010) 0.76
Incidence-based cost estimates require population-based incidence data. A critique of Mahan et al. Thromb Haemost (2011) 0.76
Hospital use, associated costs, and payer status for infants born with spina bifida. Birth Defects Res A Clin Mol Teratol (2012) 0.76
Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data. BMC Pediatr (2013) 0.76
Emergency department and inpatient hospitalizations for young people with fragile X syndrome. Am J Intellect Dev Disabil (2015) 0.75
Prevention of venous thromboembolism in pregnancy: a review of guidelines, 2000-2011. J Womens Health (Larchmt) (2012) 0.75
Understanding and improving health education among first-time parents of infants with sickle cell anemia in Alabama: a mixed methods approach. J Pediatr Hematol Oncol (2015) 0.75
Attitudes toward newborn screening for cytomegalovirus infection. Pediatrics (2011) 0.75
Sibling concordance for clinical features of Duchenne and Becker muscular dystrophies. Muscle Nerve (2014) 0.75
Correction: Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006-2010. PLoS One (2016) 0.75
CDC Grand Rounds: Newborn Screening for Hearing Loss and Critical Congenital Heart Disease. MMWR Morb Mortal Wkly Rep (2017) 0.75
Leveraging birth defects surveillance data for health services research. Birth Defects Res A Clin Mol Teratol (2014) 0.75
Newborn screening for cystic fibrosis: recommendations from the Centers for Disease Control and Prevention. Am Fam Physician (2005) 0.75
Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016. Emerg Infect Dis (2017) 0.75
Iron overload: what is the role of public health? Am J Prev Med (2011) 0.75